UK medical students' self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional study.

Journal: BMJ open

Volume: 14

Issue: 3

Year of Publication: 2024

Affiliated Institutions:  UCL Medical School, University College London, London, UK. Department of Psychiatry, University of Oxford, Oxford, UK. The Department of Psychological Medicine, King's College London, London, UK. University of Exeter Medical School, Exeter, UK. Innerspace Institute, Alentejo, Portugal. Division of Psychiatry, UCL, London, UK marco.schlosser@ucl.ac.uk.

Abstract summary 

To capture UK medical students' self-reported knowledge and harm assessment of psychedelics and to explore the factors associated with support for changing the legal status of psychedelics to facilitate further clinical research.Cross-sectional, anonymous online survey of UK medical students using a non-random sampling method.UK medical schools recognised by the General Medical Council.132 medical students who had spent an average of 3.8 years (SD=1.4; range: 1-6) in medical school.Most students (83%) reported that they were aware of psychedelic research and only four participants (3%) said that they were not interested in learning more about this type of research. Although medical students' harm assessment of psychedelics closely aligned with that of experts, only 17% of students felt well-educated on psychedelic research. Teachings on psychedelics were only rarely encountered in their curriculum (psilocybin: 14.1 (SD=19.9), scale: 0 (never) to 100 (very often)). Time spent at medical schools was not associated with more knowledge about psychedelics (r=0.12, p=0.129). On average, this sample of medical students showed strong support for changing the legal status of psychedelics to facilitate further research into their potential clinical applications (psilocybin: 80.2 (SD=24.8), scale: 0 (strongly oppose) to 100 (strongly support)). Regression modelling indicated that greater knowledge of psychedelics (p<0.001), lower estimated harm scores (p<0.001), more time spent in medical school (p=0.024) and lower perceived effectiveness of non-pharmacological mental health treatments (p=0.044) were associated with greater support for legal status change.Our findings reveal a significant interest among UK medical students to learn more about psychedelic research and a strong support for further psychedelic research. Future studies are needed to examine how medical education could be refined to adequately prepare medical students for a changing healthcare landscape in which psychedelic-assisted therapy could soon be implemented in clinical practice.

Authors & Co-authors:  Song-Smith Jacobs Rucker Saint Cooke Schlosser

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Carhart-Harris RL, Goodwin GM. The therapeutic potential of Psychedelic drugs: past, present, and future. Neuropsychopharmacol 2017;42:2105–13. 10.1038/npp.2017.84
Authors :  6
Identifiers
Doi : e083595
SSN : 2044-6055
Study Population
Male,Female
Mesh Terms
Humans
Other Terms
Cross-Sectional Studies;MEDICAL EDUCATION & TRAINING;PSYCHIATRY
Study Design
Study Approach
Country of Study
Publication Country
England